Zanamivir is an effective treatment for influenza in children undergoing therapy for acute lymphoblastic leukemia

Scandinavian Journal of Infectious Diseases

Volumn 34, Issue 8, 2002, Pages 632-633

  Maeda, Miho ^a   Fukunaga, Yoshitaka ^a   Asano, Takeshi ^a   Migita, Makoto ^a   Ueda, Takahiro ^a   Hayakawa, Jun ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; FEVER; HUMAN; IMMUNE DEFICIENCY; INFLUENZA; MAINTENANCE THERAPY; MALE; PRESCHOOL CHILD; SYMPTOM; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GUANIDINES; HUMANS; INFLUENZA, HUMAN; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PYRANS; RISK ASSESSMENT; SIALIC ACIDS; TREATMENT OUTCOME; ZANAMIVIR;

EID: 0036041706     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540210147714     Document Type: Article

References (10)

1. Influenza in children with cancer
2. Prevention and treatment of influenza in immunocompromised patients
3. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults
4. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infection
5. Zanamivir: A rational approach to influenza B
6. Use of selective oral neuraminidase inhibitor oseltamivir to prevent influenza
7. Zanamivir for treatment of influenza A and B infection in high-risk patients
8. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus
9. Influenza in children
10. Community respiratory virus infection in immunocompromised patients with cancer